Please assess the completion status of the following clinical trial:

Trial Title: Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Documented S. aureus bacteremia within 2 calendar days of the first dose of study medication~Exclusion Criteria:~* Subjects with a creatinine clearance of less than 30 ml/min~* Subjects with pneumonia~* Pregnant, nursing, or lactating~* Documented history of allergy or intolerance to penicillin or vancomycin~* Subjects with osteomyelitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).